# Fluor awarded EPC contract for Novo Nordisk diabetes API plant in North Carolina

Fluor Corp. has been awarded an engineering, procurement, construction and construction management contract by Novo Nordisk for its new $2 billion diabetes active pharmaceutical ingredient manufacturing facility in Clayton, North Carolina.

- Type: Contract
- Announced: 2016-12-20
- Where: Clayton, N.C., United States
- Value: $2.00B
- Status: announced
- Products: diabetes active pharmaceutical ingredient
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fluor](https://endata.com/companies/901.md) (partner)
- [Novo Nordisk](https://endata.com/companies/17868.md) (customer)

## Sources

- [chemengonline.com](https://www.chemengonline.com/author/gondrey/page/79/), 2016-12-21: "Fluor has been awarded an engineering, procurement, construction and construction management contract by Novo Nordisk for its new $2-billion diabetes active pharmaceutical ingredient (API) manufacturing facility in Clayton, N.C."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.